Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
EGFR S768I
i
Other names:
EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Associations
(12)
News
Trials
A2 | Sensitive
C2 | Sensitive
C3 | Sensitive
C4 | Sensitive
A2 | Resistant
C2 | Resistant
C3 | Resistant
C4 | Resistant
Show legend
Drug categories
EGFR
Tyrosine Kinase Inhibitors
Immunotherapy
Cancel
Non Small Cell Lung Cancer
Lung Adenocarcinoma
erlotinib
A2
EGFR S768I
|
Non Small Cell Lung Cancer
|
erlotinib
C4
EGFR S768I
|
Lung Adenocarcinoma
|
erlotinib
gefitinib
A2
EGFR S768I
|
Non Small Cell Lung Cancer
|
gefitinib
dacomitinib
A2
EGFR S768I
|
Non Small Cell Lung Cancer
|
dacomitinib
afatinib
A2
EGFR S768I
|
Non Small Cell Lung Cancer
|
afatinib
C3
EGFR S768I
|
Lung Adenocarcinoma
|
afatinib
bevacizumab + afatinib
C4
EGFR S768I
|
Lung Adenocarcinoma
|
bevacizumab + afatinib
osimertinib
A2
EGFR S768I
|
Non Small Cell Lung Cancer
|
osimertinib
SZMD4
C2
EGFR S768I
|
Non Small Cell Lung Cancer
|
SZMD4
MET306
C2
EGFR S768I
|
Non Small Cell Lung Cancer
|
MET306
Tyrosine kinase inhibitor
C3
EGFR S768I
|
Non Small Cell Lung Cancer
|
Tyrosine kinase inhibitor
EGFR inhibitor
C3
EGFR S768I
|
Non Small Cell Lung Cancer
|
EGFR inhibitor
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
